An observational study in Post Stroke, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-16.
Sponsored by Hospices Civils de Lyon · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Stroke by Hospices Civils de Lyon — 13 open to participants now, 14 under way, none of them phase 3. Stroke · Hospices Civils de Lyon.
Among the 40 studies in Stroke by Hospices Civils de Lyon, this one is the 12th largest by planned enrollment of the 14 observational ones that give a count, is one of 4 that started in 2025, is one of 14 observational ones, reaches primary completion later than 5 of the 13 other live ones, and was the 37th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →13 of the 40 studies in Stroke by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:
Hospices Civils de Lyon · Sites in France
Ages 18–85
Hospices Civils de Lyon · Sites in France
Ages 65–100
Hospices Civils de Lyon · Sites in France
Ages 30–80
Hospices Civils de Lyon · Sites in France
Ages 18–100
Hospices Civils de Lyon · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 4 started in 2025.
This study's planned enrollment of 80 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 50 across the 26 interventional studies, 348 across the 14 observational. Of the 22 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.
3 of the studies in Stroke by Hospices Civils de Lyon that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04197258Hospices Civils de LyonEvaluation of the Impact of an Individual Peer Support Intervention for Stroke Patients When Returning Home: a Mixed Methods Pilot Study | 2026-12-05 |
| NCT05874154Hospices Civils de LyonEvaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach | 2027-03-02 |
| NCT06306144Hospices Civils de LyonEarly-phase Telecare Programs for Minor Stroke | 2027-09-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 40 studies in Stroke by Hospices Civils de Lyon, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This observational study aims to assess the perception of advanced rehabilitation technologies among three key groups involved in stroke recovery: post-stroke patients, physicians specialized in Physical and Rehabilitation Medicine, and allied health professionals. The study is conducted at HCL - Renée Sabran Hospital , specifically within the Kermes 2 department. Participants are selected using a non-probability sampling method, based on predefined inclusion and exclusion criteria. Data will be collected using a structured, author-developed questionnaire designed to evaluate attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The questionnaire is applied at a single time point after obtaining informed consent. This research responds to the growing integration of technology in neurorehabilitation and seeks to identify potential barriers or facilitators to its adoption in clinical practice.
The hypothesis is that there is a significant difference in perception and acceptance of advanced rehabilitation technologies between the three groups, influenced by their respective roles, experience, and level of exposure to such technologies.
Participants will be recruited from HCL - Renée Sabran Hospital, located in the PACA region (Provence-Alpes-Côte d'Azur), specifically from the Kermes 2 department, as well as through professional medical networks. The study population includes three main groups: (1) patients with a confirmed diagnosis of stroke, whether or not they have been exposed to advanced rehabilitation technologies; (2) physicians specialized in Physical and Rehabilitation Medicine involved in stroke management; and (3) allied health professionals (e.g., physiotherapists, psychologists, occupational therapists, speech therapists, neuropsychologists, psychomotor therapists) actively working in post-stroke rehabilitation settings. Recruitment will focus on individuals affiliated with institutions offering neurological rehabilitation services.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group includes patients with a confirmed diagnosis of stroke, hospitalized or followed at HCL - Renée Sabran Hospital (Kermes 2 department), regardless of whether they have previously used advanced rehabilitation technologies.
Other: completion of a structured questionnaire
This group consists of physicians specialized in Physical and Rehabilitation Medicine, actively involved in the treatment and rehabilitation of post-stroke patients. Recruited from HCL - Renée Sabran Hospital and affiliated professional networks
Other: completion of a structured questionnaire
This group includes allied health professionals involved in stroke rehabilitation, such as physiotherapists, occupational therapists, psychologists, speech therapists, neuropsychologists, and psychomotor therapists. All participants are affiliated with the HCL - Renée Sabran Hospital or collaborating institutions
Other: completion of a structured questionnaire
completion of a structured questionnaire
Perceptions of post-stroke patients, physical medicine and rehabilitation physicians and auxiliary medical staff on Advanced Rehabilitation Technologies.
The primary outcome measure evaluates the perception of advanced rehabilitation technologies among key stakeholders involved in post-stroke recovery. This perception is assessed using a structured questionnaire specifically developed by the authors, designed to capture attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The instrument is applied to three target groups: post-stroke patients, physicians specializing in physical and rehabilitation medicine, and allied health professionals. This measure provides critical insights into the acceptability and potential integration of advanced technologies in neurorehabilitation practice.
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Jul 2026, 12 months after the start.
Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 12 months is below that.
Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.